Tags : New Company

Merck & Co. to Spin-Off its Non-Core Business into a

Shots: Merck will spin-off its women’s health, trusted legacy brands and biosimilars businesses into a new company with an objective to retain its focus in its core therapy areas including oncology, vaccines, hospital & animal health NewCo will focus on women health’s product, Nexplanon (etonogestrel implant) franchise and fueled by its leading contraceptive and fertility […]Read More